Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 02, 2023, titled "Zydus and Guardant Health to jointly promote the Guardant360�� portfolio of next-generation genomic tests for advanced solid cancers in India and Nepal".
Press Release Nov 02 2023
Filed with NSE · · 4 pages · English
Summary by 6ix AI
The partnership aims to enhance precision oncology by providing oncologists with tools to make informed treatment decisions based on patients' genomic profiles. This agreement reflects a commitment to improve patient outcomes and address unmet cancer treatment needs in the region.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Oct 31 2023
- Press Release Oct 30 2023
- Press Release Oct 25 2023
- Press Release Oct 20 2023
- Press Release Oct 16 2023
Later from Zydus Lifesciences
- Press Release Nov 03 2023
- Zydus Lifesciences Limited Press Release Nov 06 2023
- Press Release Nov 07 2023
- Press Release Nov 10 2023
- Press Release Dec 01 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences